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ABSTRACT
￿
Somatostatin is a 14-amino acid peptide hormone that inhibits the secretion of a
variety of other polypeptide hormones, including growth hormone . Here we describe an
experimental system used to determine whether somatostatin can discriminate in its inhibition
between secretory and plasma membrane proteins . Growth hormone-secreting cells (GH3)
were infected with vesicular stomatitis virus and pulse-chased with ["S]methionine to follow
the simultaneous intracellular transit of growth hormone and the viral membrane glycoprotein,
G protein . Secretion of growth hormone was monitored by immunoprecipitation of chase
media, while appearance of G protein on the plasma membrane was detected by cell surface
labeling and virus purification. In the presence of somatostatin (10 Ag/ml), the secretion of
growth hormone was inhibited by 80%. In contrast, G protein appeared on the plasma
membrane with slightly enhanced kinetics. When cells were treated with the ionophore
monensin (0.2 pM), there was a dramatic inhibition of both the secretion of growth hormone
and the incorporation of G protein into plasma membranes. Our results on the differential
effect of somatostatin provide evidence for sorting of secretory and membrane proteins into
distinct compartments in the secretory pathway. The data further suggest that this sorting
event occurs late in the Golgi complex or after proteins exit from that organelle.
In eucaryotic cells, the secretory pathway serves not only to
ensure the efficient export of proteins from the cell, but also
to deliver proteins to the plasma membrane and other organ-
elles (23). Commitment of all proteins into this pathway
appears to proceed by a common mechanism, which results
in co-translational insertion of the nascent polypeptides into
or through the membrane ofthe roughendoplasmic reticulum
(RER)' (5). The subsequent directed transit of different pro-
teins from the RER through elements of the secretory appa-
ratus has been described in many systems (20). However, the
basic mechanisms governing how movement is regulated and
how the ultimate localization ofdifferent proteins is achieved
remain to be determined. Secretory proteins and plasma
membrane proteins, for example, traverse the entire pathway,
from the RER through the Golgi apparatus, terminating in
an exocytic fusion of vesicle membranes with the plasma
'Abbreviations used in this paper:
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membrane. In this process, both classes of proteins undergo
mar,, similar co- and posttranslational modifications (e.g.,
glycosylation, sulfation, proteolytic cleavage), indicative of
their having resided in functionally similar compartments (9).
However, it might be expected that different mechanisms
would govern transport of soluble proteins and those em-
bedded in lipid bilayers. In support of this hypothesis, recent
studies have provided evidence that in certain differentiated
cell types, secretory and plasma membrane proteins reach the
cell surface at different rates (10, 14, 17, 27), and may be
physically segregated from each other during transport (14).
In order to investigate the molecular mechanisms underlying
these phenomena, we developed a model system to study the
intracellular sorting of secretory and plasma membrane pro-
teins that exploits the physiological action of somatostatin
(SRIF) to perturb protein transport.
Somatostatin (SRIF) is a 14-amino acid peptide hormone
synthesized by various tissues, e.g., endocrine pancreas, hy-
pothalamus, extrahypothalamic brain, and gastrointestinal
epithelium (24, 26). Its primary physiological action is to
inhibit the secretion of a corresponding array of other poly-
97peptide hormones such as growth hormone, prolactin,insulin,
and glucagon (24). Though it is known to interact with high-
affinity surface receptors on target cells (25), the intracellular
site at which it arrests secretory protein migration has not
been analyzed. However, its rapid and local action (31) sug-
gests that it perturbs late events in secretion. Furthermore,
this role implies that it would be a powerful agent that could
be used to selectively inhibit secretion without necessarily
affecting assembly and turnover of plasma membrane com-
ponents.
We therefore studied the effect ofSRIF on the intracellular
transit ofa typical secreted protein, rat growth hormone (rGH)
(2), and a model plasma membrane-like protein, the G protein
of vesicular stomatitis virus (VSV) (3, 16, 21), in the growth
hormone-secreting (GH3) rat pituitary cell line. GH3 cells
synthesize and secrete large amounts of rGH (30), possess
surface SRIF receptors (25), and can be infected by VSV. We
report here that SRIF inhibits the exit of newly synthesized
rGH but allows G protein to appear on the plasma membrane
in the same cells. Our data imply that rGH and VSV G
protein are sorted during intracellular transport into physi-
cally or functionally distinct compartments.
MATERIALS AND METHODS
Cells and Viral Infection:
￿
GH3 cells (obtained from Dr. L. Reid,
Albert Einstein College ofMedicine) had been in continuous culture for several
years and were a mixture of flattened and rounded, but adherent, cells. Cells
were routinely propagated in RPMI 1640 medium (Gibco Laboratories, Grand
Island, NY) supplemented with 10% fetal bovine serum (Flow Laboratories,
McClean, VA), in a 95% air-5% C02 humidified incubator. For experiments,
cells were plated in 35-mm plastic dishes, and grown to near confluence.
Dexamethasone (Sigma Chemical Co., St. Louis, MO) was added from a stock
solution to a final concentration of0.1 1AM. VSV (Indiana serotype, a gift of
Dr. E. Rodriguez-Boulan, Downstate Medical Center), was propagated in GH3
cells using a low multiplicity of infection. Viral titers, assessed by cytopathic
effect (CPE) on GH3 cells in 96-well microtiter dishes, were routinely 10'-10'
CPE 50/ml; there was no significant reduction in titer after several such
passages. For viral infection experiments, cells were washed in protein-free
saline, and viruses (at a multiplicity of 10-15 CPE 50/cell) were adsorbed in
0.2 ml of serum-free medium for 45 min at 37°C, after which 2 ml of RPMI
1640 containing2% fetal bovine serum wasadded. In preliminary experiments,
cells were subjected to pulse-labeling with [3'S]methionine at hourly intervals
after infection, which revealed peaksynthesis ofG protein 3.5-5 h afteraddition
of virus.
Biosynthetic Labeling: For pulse-chase experiments, growth me-
dium was replaced with RPMI lacking unlabeled methionine (Selectamine kit,
Gibco Laboratories) that contained 50 ACi/ml ["S]methionine (1,040 Ci/
mmol); Amersham Corp., Arlington Heights, IL) and cells were incubated for
5 or 10 min as indicated. The chase medium consisted ofcomplete RPMI 1640
containing 10% serum and 10 mM unlabeled methionine. Where indicated,
somatostatin-14 (Boehringer Mannheim Biochemicals, Indianapolis, IN) was
added from a stock solution of 1 mg/ml dissolved in 0.1 N acetic acid, and
monensin (Calbiochem-Behring Corp., La Jolla, CA) from a 5-mM stock
solution in ethanol. Cells were exposed to SRIF or monensin only after the
pulse, in order to test the effect of these reagents on intracellular transit of
newly synthesized rGH. Cells were harvested by scraping, lysed in 100 ,u1 PBS
containing 0.5% (wt/vol) deoxycholate, 0.5% (vol/vol) Nonidet P-40, and a
cocktail of protease inhibitors (100 U/ml trasylol, 200 Kg/ml soybean trypsin
inhibitor, 1 mg/ml benzamidine, I mg/ml f-aminocaproic acid, and 0.35 mg/
ml phenylmethylsufonyl fluoride, all purchased from Sigma Chemical Co.).
Nuclei were removed by centrifugation for 2 min in a Brinkmann microfuge,
and the postnuclear supernatants were prepared for immunoprecipitation or
directly for SDS PAGE.
Immunoprecipitation of Rat Growth Hormone:
￿
Aliquots of
postnuclear supernatants and chase media were subjected to immunoprecipi-
tation using a baboon anti-rat growth hormone antiserum (a kind gift of Dr. F.
Carter Bancroft, Memorial Sloan-Kettering Cancer Center). 10 kl ofthis serum
quantitatively precipitated pulse-labeled rGH from 5 x 106 dexamethasone-
treated GH3 cells (not shown.) Immune complexes were isolated by incubation
with Protein A-Sepharose beads (Sigma) and resolved by SDS PAGE using a
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7-15%gradient ofacrylamide. Gelsweresubjected to fluorographyandexposed
to Kodak XAR film at -70°C. The resulting fluorogaams were scanned using
a Beckman DU-8 spectrophotometer with an integrating function (Beckman
Instruments, Inc., Palo Alto, CA).
Virus Purification:
￿
Chase media were clarified by centrifugation for
30 s in a microfuge, after which aliquots were diluted in THE (100 mM Tris-
HCI, pH 7.4, 50 mM NaCl, 10 mM EDTA), and centrifuged for 4 h at 39,000
rpm in an SW41 rotor at 4°C. Viral pellets were dissolved directly in SDS gel
loading buffer and resolved by SDS PAGE as outlined above. Viruses isolated
by this procedure were essentially free of contaminating cellularproteins.
Cell Surface Labeling:
￿
At the indicated chase times, cultures were
chilled, and all subsequent steps were performed at 0°C. Cells were washed
three times in PBS-T (125 mM NaCl, 25 mM NaP0,, pH 8.0) and incubated
in 10 mM trinitrobenzene sulfonate (picrylsulfonic acid, Sigma) in PBS-T for
30 min. After three washes in PBS-T, and one in PBS-T containing 1 mg/ml
BSA, intact cells were exposed to rabbit anti-dinitrophenol (DNP) antiserum
diluted 1:2 in PBS-T for an additional 60 min. Cells were washed extensively
and harvested as above, and 25 Wl ofpacked protein A-Sepharose beads(Sigma)
was added directly to the resultant postnuclear supernatants. Immune com-
plexes were isolated by centrifugation and prepared for SDS PAGE.
Preparation of Anti-DNP Antiserum:
￿
In preliminary cell surface
labeling experiments wetestedcommercially available rabbit anti-DNPantisera
from several sources, as well as a murine monoclonal anti-DNP antibody. In
all cases, the result was a faint or undetectable labeling of VSV G protein with
high background labeling of other viral and cellular proteins. We therefore
raised high titer antisera in rabbits by multisite subcutaneous injection of a
DNP-hemocyanin conjugate (prepared by Dr. B. Birshtein, Albert Einstein
College ofMedicine). Antigen was resuspended in Freund's complete adjuvant
for the initial immunization, followed at 2-wk intervals by similar injections of
antigen in Freund's incomplete adjuvant. Anti-DNP titers were assessed by
Ouchterlony double immunodiffusion; positive bleeds were then assayed di-
rectly in cell surface labeling experiments as described above. The use of this
antiserum resulted in a l0-fold higher labeling than was seen with commercial
antisera. Nonetheless, even using undiluted antiserum (1 ml per 5 x 106 cells),
the proportion of pulse-labeled G protein that can be immunoprecipitated is
low, as has been described previously (27). This is presumably due to an
efficient coupling oftrinitrophenol (TNP) moieties to an excess ofnonradioac-
tive surface molecules which compete with radiolabeled G molecules for
antibody binding. However, it is assumed that an equal proportion of surface
molecules are detected by this procedure in each case (27).
Endoglycosidase H Digestions:
￿
VSV-infected cells were pulse-
labeled with ['3S]methionine for 5 min and chased for 10-min intervals. Cells
were harvested directly into 1% SDS (100 ,ui per 35-mm dish), sonicated, and
boiled. Two 40-,l aliquots ofeach lysate were adjusted to a final concentration
of 0.3% SDS and 0.2 M Na citrate, pH 5.5. 2 Al of endoglycosidase H (Endo
H) (9.08 U/ml, a gift of Dr. P. Atkinson, Albert Einstein College of Medicine)
was added to one replicate sample, while the control received an equal volume
ofbuffer. Incubation was at 37°C for 16 h, after which samples were prepared
for SDS PAGE directly.
Immunofluorescence:
￿
Immunofluorescent staining ofinfected cells
was performed essentially as described previously (12). Rabbit anti-VSV anti-
serum was kindly provided by Dr. E. Rodriguez-Boulan.
RESULTS
Synthesis and Transport of Growth Hormone and
VSV G Protein in Infected Cells
The goal of our experiments was to monitor the simulta-
neous transit of rGH and G protein through the secretory
pathway in GH3 cells. It was therefore necessary to biosyn-
thetically label both proteins in the RER using a short pulse,
chase for increasing times, and assay for rGH secretion and
the appearance ofG protein on the plasma membrane. How-
ever, VSV infection rapidly shuts off host protein synthesis in
many cells (34). Preliminary experiments revealed that infec-
tion of GH3 cells with a multiplicity of infection sufficient to
induce large quantities of G protein resulted in a general
inhibition of synthesis of host proteins, including rGH, within
3 h after infection. Although the mechanism of VSV-induced
translational inhibition is controversial, it has been suggested
to result from simple competition between host mRNAs, andFIGURE 1
￿
Synthesis and secretion of
growth hormone in the absence
and presence of viral infection .
Mock-infected (-VSV) and VSV-in-
fected (+VSV) GH 3 cells (all pre-
treated with dexamethasone) were
pulse-labeled for 10 min at 4.5 h
postinfection with 50 ACi/ml of
["S]methionine, and harvested im-
mediately (lanes P) or chased with
unlabeled methionine for 0, 20, 40,
and 60 min as indicated . Intracel-
lular growth hormone (rGH) was
immunoprecipitated from equiva-
lent amounts of postnuclear super-
natants (lanes P), and secreted rGH
was measured in an equivalent
amount of extracellular medium
(lanes 0, 20, 40, and 60) by treat-
ment with 10 ul of baboon anti-
rGH (as described in Materials and
Methods) . The resulting immuno
precipitates were resolved by SDS PAGE using gradients of 7-15% acrylamide . After electrophoresis the gels were subjected to fluorography
and exposed for 1 wk. A parallel analysis using rabbit anti-rat prolactin antibody revealed that this strain of GH 3 cells produces little rat
prolactin which was further suppressed by dexamethasone treatment (not shown) .
an excess of viral mRNAs, for the translational machinery
(18). We therefore attempted to circumvent the inhibition of
rGH specifically by raising the intracellular cencentration of
rGH mRNA . To this end, cultures were treated with the
synthetic glucocorticoid dexamethasone for several days be-
fore infection, since it is well documented that glucocorticoids
stimulate rGH transcription in these cells (7) . Optimally, cells
were incubated with 0 .1 AM dexamethasone for 48 h, then
infected with VSV at a multiplicity of 10 CPE 50/cell or
mock-infected, and labeled for 10 min with ['SS]me-
thionine 4.5 h later . Quantitative immunoprecipitation of
pulse-labeledrGH from equivalent amounts ofmock-infected
and VSV-infected cells demonstrated that significant levels of
rGH synthesis were maintained after infection, when cells
were pretreated with dexamethasone (Fig. 1) . Thus, as pre-
dicted, increasing the relative concentration of rGH mRNA
apparently allowed it to compete successfully with VSV
mRNAs in initiation of translation .
To determine the kinetics ofrGH secretion in control and
VSV-infected cells, we isolated pulse-labeled rGH by immu-
noprecipitation of chase media and analyzed it on SDSPAGE
(Fig. 1) . Low levels ofrGH could be detected at the first chase
point (20 min) and were maximal by 60 min of chase . It
appeared that the majority of pulse-labeled rGH was extra-
cellular at this time in control (uninfected) cells, and similar
results were obtained for VSV-infected cells. Quantitation of
rGH secretion kinetics by densitometric scanning ofthe fluo-
rograms revealed that rGH exits with a half-time of 35-40
min (see Fig . 4A). Most significantly, the rate of secretion of
rGH, as well as the absolute amounts secreted, were not
altered by viral infection, indicating that there was little or no
disruption of normal secretory processes under our experi-
mental conditions.
Two complementary methods were employed to measure
the appearance of newly synthesizedG protein in the plasma
membrane of infected cells (Fig. 2) . First, virus particles were
isolated from chase media and analyzed for their content of
labeledG protein . This serves as an assay for the functional
integration ofG protein into regions ofthe plasma membrane
from which virus budding occurs. However, since it was
conceivable that SRIF might allow G protein to reach the
plasma membrane but interfere with a later step of virus
assembly, we also measured cell surface G protein directly .
Intact cells were exposed to trinitrobenzene sulfonate (TNBS),
which results in the covalent linkage of TNP moieties to
externally exposed proteins (6, 15) . This was followed by
immunoprecipitation of TNP-tagged molecules with anti-
DNP antibodies and gel electrophoresis of the immune com-
plexes . Treatment of intact cells withTNBS (Fig . 2A) resulted
in the isolation ofincreasing amounts oflabeledG molecules
with longer durations of chase . Though there is background
labeling of other viral proteins, the only species that exhibits
pulse-chase behavior migrates slightly slower than pulse-la-
beled G (Fig . 2A, compare lanes P and 60). This increase in
apparent molecular weight is consistent with processing of
oligosaccharide moieties that accompanies G transit from the
RER through the Golgi region (see below.) The time required
for half of the labeled G molecules to reach the plasma
membrane was 45 min (see Fig. 4B) . Chase incubations >60
min, followed by TNBS labeling, revealed a depletion in the
amount ofplasma membrane-associatedG (not shown). This
presumably resulted from G protein incorporation into vi-
rions (Fig. 2B), which closely followed its appearance in the
plasma membrane (6,2 of incorporation = 45-50 min), indi-
cating a short residence time ofG in the plasma membrane .
The viral L, N, andNS proteins appeared in virions in parallel
with G, while newly synthesized M protein molecules exited
much more rapidly, as has been reported for VSV replication
in other cell types (1).
A more detailed analysis ofG protein migration was facil-
itated by the presence of N-linked carbohydrate moieties on
this protein . Core high mannose oligosaccharides added to
nascent G molecules co-translationally in the RER are sensi-
tive to Endo H, while galactose- and sialic acid-containing
carbohydrates on matureG are resistant to the action of this
enzyme (28) . Endo H resistance is acquired during migration
of the protein through the Golgi cisternae (most probably
trans elements) which contain the carbohydrate-modifying
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99enzymes (22) . Thus, the time required for acquisition of Endo
H resistance can be used to approximate the rate of transfer
of glycoproteins from the RER to the trans Golgi complex .
Infected GH 3 cells were pulse-labeled for 5 min and chased
for l0-min intervals, and total cell lysates were subjected to
digestion with Endo H (Fig. 2C) . G protein labeled during
this shorter pulse was completely sensitive to this enzyme, as
expected for localization in the RER . Endo H-resistant forms
appeared rapidly ; by 10 min ofchase at least one intermediate
in carbohydrate processing could be observed, though full-
sized Endo H-resistant forms were not apparent until 20 min
ofchase . By 30 min of chase, 80% of labeled G was rendered
resistant to Endo H .
It therefore appears that newly synthesized G protein travels
from the RER to trans elements of the Golgi complex with a
half-time of 15-20 min (Fig . 2C; see also Fig. 6), reaches the
plasma membrane 20-30 min later, and is rapidly incorpo-
rated into budding virions. Taken together, these data indicate
that under the conditions of infection used for these experi-
ments, both rGH and VSV G protein are synthesized in large
amounts and traverse the secretory pathway at approximately
equivalent rates .
00
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FIGURE 2 Intracellular transport of VSVG protein inGH 3
cells . (A) Cell surface labeling. Cells were pulse-labeled
(at 4.5-5 h after infection) with 50 pCi/ml of ['SS]-
methionine for 10 min, chased for 0, 20, 40, and 60
min, and quickly chilled . The cells were then subjected
to TNBS labeling, and the ["S]methionine TNP-conju-
gated plasma membrane proteins were detected by
immunoprecipitation with anti-DNP antiserum, fol-
lowed by resolution of the immune complexes on SDS
PAGE . Lane P shows the postnuclear supernatant of
cells harvested immediately after the pulse, and con-
tains one-fifth the cellular material represented in lanes
0-60. (8) Assembly of mature virus particles . Viruses
radiolabeled with ["S]methionine were pelleted from
the chase media at 0, 20, 40, and 60 min chase points,
and analyzed directly on SDS PAGE . (C) Kinetics of VSV
G protein glycosylation . Infected cells were pulsed for
5 min with 50 WCi/ml ['SS]methionine and chased for 0,
10, 20, and 30 min (5'P, 10'C, 20'C, and 30'C), after
which total cell lysates were prepared and divided into
two equal aliquots . One aliquot was subjected to diges-
tion with Endo H for 16 h at 37°C (+), while the other
was incubated with an equal volume of buffer (-) . The
resulting material was analyzed by SDS PAGE as out-
lined above . Downward-pointing arrows indicate Endo
H-sensitive species of G protein ; upward-pointing ar-
rows indicate Endo H-resistant forms . The migration of
the virion marker proteins G, N, NS, andM are indicated
in each panel .
Effect of SRIF on Intracellular Transport of rGH
and VSV G Protein
Previous studies on SRIF action inGH 3 cellsand in primary
pituicyte cultures have measured the inhibition of release of
total cellular rGH by radioimmunoassay (4, 25, 32). Thus, it
was necessary to establish (a) that SRIF would be effective in
inhibiting the externalization ofnewly synthesized rGH using
a pulse/chase protocol, and (b) that viral infection would not
disrupt the surface receptor-mediated response to SRIF . It
should be emphasized that our experimental protocol was
designed to assess the effect ofSRIF on the intracellular transit
of presynthesized rGH . Consequently, cells were treated with
SRIF after the pulse-labeling period, thus avoiding any pos-
sible effect of SRIF on rGH synthesis per se . Preliminary
experiments in uninfected cells revealed that continuous ex-
posure of cells to SRIF for the entire chase period resulted in
75-80% inhibition of secretion of pulse-labeled rGH-immu-
noreactive material . These experiments also demonstrated
that prior treatment with dexamethasone did not alter the
magnitude of this response . When cells were infected with
VSV as described above, they were equally responsive to SRIFFIGURE 3 Effect of somatostatin on the intracellular transport of
rGH and VSVG protein . VSV-infected GH 3 cells were pulsed with
["S]methionine for 10 min at 4.5 h postinfection (in the absence of
SRIF), and chased for 20, 40, and 60 min in the absence (-SRIF) or
presence (+SRIF) of 10 gg/ml SRIF . (A) Secreted rGH . Pulse-labeled
rGH was isolated from chase media at the times indicated by
immunoprecipitation with baboon anti-rGH antiserum . (B) Cell
surface VSV G protein . At the indicated times, cells were chilled,
and the surface proteins were labeled using the TNBS procedure,
followed by immunoprecipitation with anti-DNP antiserum . (C)
Assembly of mature virions . Viruses were isolated from the chase
media by centrifugation as described in Materials and Methods . In
all three panels, samples were analyzed by SDS PAGE on 7-15%
gradient gels, followed by fluorography .
action, and rGH secretion was inhibited by 80% overall (Figs.
3A and 4A).
In contrast, SRIF did not inhibit the simultaneous transit
ofVSV G protein to the plasma membrane (Fig. 3B) ; acces-
sibility of pulse-labeled G protein to TNBS conjugation was
consistently increased by the hormone . In the presence of
SRIF, G protein was incorporated into plasma membranes
with a half-time of 30-40 min, as compared with 45 min in
untreated controls . This result was confirmed by the isolation
of mature virions (Figs . 3C and 4B), in which G protein
appeared more rapidly than in control cells (t112 = 35-40 min
as compared with 45-50 min). The other viral structural
proteins were also externalized more rapidly in the presence
of SRIF, implying that virus assembly as a whole was en-
hanced by the hormone . This might be due to a more rapid
mobilization ofG protein into plasma membranes, providing
more nucleation sites for virus budding . We conclude from
these experiments that SRIF allowed G protein to reach the
plasma membrane, and to be incorporated into virions, while
simultaneously inhibiting the secretion of rGH in the same
cultures .
It could be argued that the differential effect of SRIF
resulted from a non-uniform infection of the cells with VSV .
If this were the case, uninfected cells could synthesize rGH
and respond to SRIF . Infected cells in the same culture,
rendered refractory to the action of SRIF by the cytopathic
effect of VSV, could synthesize and transport G protein
irrespective of the presence of the hormone . Though the
multiplicity of infection used and the maintenance of rGH
synthesis and secretion observed (Fig. 1) rendered this possi-
bility unlikely, we nevertheless tested it directly by subjecting
cells to indirect immunofluorescent staining using anti-VSV
antibody and rhodamine-conjugated second antibody (Fig .
5) . Under the conditions of infection used, >90% ofthe cells
exhibited high levels of viral-specific immunofluorescence .
Most of the cells were highly infected and rounded; in some,
it is possible to see perinuclear and peripheral staining char-
acteristic of Golgi complex and plasma membrane, respec-
tively . This result suggested that the differential effect ofSRIF
could not be explained on the basis oftwo subpopulations of
GH 3 cells .
Effect of Monensin on Intracellular Transit
The data presented above demonstrate that the intracellular
pathways ofrGH and VSV G protein can be distinguished by
their sensitivity to the inhibitory effect of SRIF, which prob-
ably acts at a relatively late step in the secretory pathway . We
MINUTES
FIGURE 4 Kinetics of rGH and
VSV G externalization . The fluo-
rograms shown in Fig . 3 were ana-
lyzed by densitometric scanning
(see Materials and Methods), and
the integrated absorbances were
plotted in arbitrary units . (A) rGH
secretion in the absence (9) and
presence (p) of SRIF . The dotted
line represents rGH secreted by
parallel cultures of mock-in-
fected, dexamethasone-treated
GH3 cells (see Fig . 1) . (B) VSV G
protein release . Detection on the
cell surface, minus SRIF (A) and
plus SRIF (A) ; assembly of virions,
minus SRIF (0) and plus SRIF (p) .
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10 1FIGURE 5 Assessment of viral infection by immunofluorescent
staining of VSV-infected GH3 cells . Cells grown on coverslips were
infected at a multiplicity of 10-15 CPE 50/cell, fixed 5 h later, and
subjected to indirect immunofluorescence using rabbit anti-VSV
antiserum followed by rhodamine-conjugated goat anti-rabbit IgG .
(A) Rabbit anti-VSV antiserum ; (B) nonimmune rabbit serum . Mock-
infected cultures stained with anti-VSV antiserum appeared as in B .
x 1,331 .
therefore wished to determine the point in the secretory
pathway at which rGH and G protein might diverge . To this
end we tested the effect of the ionophore monensin on the
simultaneous transit of rGH and G protein ; this compound
has been shown to block the transport ofmany secretory and
membrane proteins through the Golgi region (29) . GH 3 cells
were infected with VSV, pulse-labeled, and chased in the
presence or absence of 0.2 jM monensin (Fig . 6) . Monensin
effectively blocked the secretion ofrGH and the externaliza-
tion of G protein, to the same extent, at all time points
measured (Fig. 6, a and b) . In addition, this agent also
inhibited virus assembly, as evidenced by a concomitant
decrease in the incorporation of the other labeled viral struc-
tural proteins into mature virions (not shown).
To determine the site of monensin-mediated arrest within
the Golgi apparatus, control and monensin-treated infected
cell lysates were digested with Endo H and analyzed by SDS
PAGE . VSV G protein acquired resistance to Endo H in the
presence of monensin (Fig. 6C), indicating that the drug
allowed G protein access to the trans element of the Golgi .
However, the time required for acquisition of complex car-
bohydrates and hence Endo H resistance was significantly
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longer in the presence of monensin (Fig . 6C; t1/2 = 25 min as
compared with 15 min in controls) . This suggests that in these
cells, 0.2 uM nomensin delays transport through proximal
elements of the Golgi complex in addition to inhibiting exit
from this organelle . In this regard,G protein that accumulated
intracellularly in the presence of monensin had a slightly
smaller apparent molecular weight than mature G protein
(not shown) ; this was presumably due to the absence ofsialic
acid residues on these molecules (27). On the basis of these
results, we tentatively conclude that rGH and VSV G protein
traverse the Golgi apparatus in parallel, and are subsequently
diverted into functionally different pathways .
DISCUSSION
The experiments described here demonstrate that VSV-in-
fectedGH3 rat pituitary cells represent a useful model system
for studying intracellular transport and sorting of secretory
and plasma membrane proteins, in this case, rat growth
hormone and VSV G protein . By manipulating the dose and
duration of dexamethasone pretreatment to stimulate rGH
transcription, as well as by titrating the multiplicity of virus
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FIGURE 6
￿
Effect of monensin on the kinetics of rGH and VSV G
protein intracellular transport . Infected cells were pulse-labeled
with [ 35S]methionine at 5 h postinfection and chased in the absence
(closed symbols) or presence (open symbols) of 0.2 juM monensin .
rGH was detected by immunoprecipitation from chase media, and
cell surface and virion-associated G protein were measured by
TNBS labeling and virus isolation as described in the legend to Fig .
2 . Endo H digestion of control and monensin-treated cultures was
as described in Materials and Methods and the legend to Fig . 2C .
All samples were resolved on 7-15% gradient SDS gels and fluo-
rographed, and the fluorograms were quantitated by densitometry .
Values are plotted in arbitrary units . (A) Secretion of rGH in the
absence (9) and presence (O) of monensin . (B) Cell surface G
protein, minus monensin (A), plus monensin (p) ; G protein in
virions, minus monensin (*), plus monensin (O) . (C) Acquisition of
Endo H resistance minus monensin (0) and plus monensin (O) .
30 40used for infection, we were able to establish conditions in
which uniformly infected cultures synthesize and externalize
large amounts of both proteins. This protocol enabled us to
test the effect of SRIF, a ubiquitous physiological modulator
of peptide hormone secretion, on the simultaneous transit of
rGH and G protein. The results indicate that SRIF selectively
inhibits the secretion of rGH while allowing the externaliza-
tion of VSV G protein. In contrast, monensin, an ionophore
that disrupts the Golgi apparatus, blocks transit of both pro-
teins. These data provide evidence that the two proteins are
effectively sorted at some point during their passage through
the secretory pathway, an event that probably occurs late in
the Golgi apparatus or after exit from that organelle.
On the basis of kinetic analyses, evidence has accumulated
from other systems suggesting that traffic of secretory and
membrane proteins through the secretory pathway is highly
regulated and is not accomplished by bulk flow of RER
membrane and content. For example, Strous, Lodish, and co-
workers (17, 27) demonstrated that several serum proteins (as
well as VSV G protein) have distinct rates of secretion from
HepG2 hepatoma cells. Using acquisition of Endo H resist-
ance to determine transfer though the Golgi apparatus, they
ascribed these differencesto different ratesoftransfer between
RER and Golgi, and concluded that after exiting from the
Golgithe proteins travel at equivalent rates. Similarly, Fitting
and Kabat (10) have shown that two retroviral glycoproteins,
gp70env and gp93m, reach the plasma membrane of trans-
formed cells with distinctly different kinetics; they postulate
a selection mechanism (perhaps receptor-mediated) that may
operate at the level of the RER. Regulation of transit also
occurs in AtT-20 pituitary cells, but at a later stage in the
secretory pathway. This cell line, studied extensively by Gum-
biner and Kelly (14), secretes both the precursor polypeptide
proopiomelanocortin and adrenocorticotropin which is de-
rived from it by proteolysis; and also expresses an endogenous
retroviralglycoprotein on the cell surface. Proopiomelanocor-
tin and viral glycoprotein molecules are secreted rapidly, via
a "constitutive" pathway. In contrast, mature adrenocortico-
tropin molecules, and a set of sulfated proteoglycans, are
packaged into secretory granules and released more slowly, in
a secretagogue-sensitive manner, which may represent an
alternative, "regulated," pathway (13, 14, 19).
Our experimental system differs from those described above
in that we have not observed major differences in transit times
ofrGH and VSV G protein. There is no apparent intracellular
accumulation of newly synthesized rGH analogous to that
seen with mature adrenocorticotropin in AtT-20 cells. Al-
though such accumulation has been reported in GH3 cells,
the strain of cells used in this study had been in continuous
culture for several years and had presumably lost this differ-
entiated function. In fact, in our experiments, rGH (which is
transported via a SRIF-sensitive pathway) reaches the plasma
membrane slightly faster than G protein (tl1Z of 35-40 min as
compared with 45 min). This result implies that intracellular
sorting, even into differentially regulated pathways, may not
necessarily result in measurable differences in transport ki-
netics. It could be argued, however, that these two proteins
traverse most ofthe secretory pathway in tandem, possibly in
the same vesicles, and are only segregated from each other at
a very late stage. Consequently, differences in transfer rates
afterthis point might not contribute significantlyto the overall
rates of secretion. The possibility of late sorting of VSV G
protein and rGH is suggested by the observation that SRIF
causes G protein to reach the surface slightly faster than in
untreated controls (Fig. 3), without altering the rate at which
it acquires Endo H resistance (not shown). Thus,this phenom-
enon may represent a specific effect on post-Golgi complex
vesicles into which G protein has been segregated.
An alternative explanation of our data is that rGH and G
protein travel the length of the secretory pathway in the same
vesicles, and that sorting ofthe two occurs as a result of SRIF
action. That is, SRIF may cause the content of a secretory
vesicle to be retained intracellularly, while allowing the vesicle
membrane and its resident proteins to fuse with the plasma
membrane. Such a process would be analogous to the disso-
ciation of asialoglycoprotein from its receptor that occurs in
an endosomal compartment following receptor-mediated en-
docytosis (11). Subsequent to this, receptors recycle to the
plasma membrane, while ligand remains in the cell. This
implies thatthe membrane and content ofsuch vesicles should
be considered as distinct compartments. In our case, the
enhanced externalization of G protein caused by SRIF may
be a direct result of such an uncoupling of secretory vesicle
membrane and content. Localization of G protein and rGH-
containing vesicles by immunoelectron microscopy, as well
as physical isolation of such vesicles by subcellular fractiona-
tion ofcontrol and SRIF-treated cells, should indicate whether
the two proteins are physically, as well as functionally, segre-
gated.
Our experiments also raise several questions concerningthe
mode of SRIF action. Numerous studies have suggested that
changes in cortical cAMP and/or Ca" ion concentrations
mediate the inhibitory effect of SRIF on secretion (4, 8, 33).
Our data imply that whatever the nature of the second mes-
senger(s) involved, SRIF causes a selective, and perhaps local,
modulation ofexocytic processes. Thus, further detailed anal-
ysis of SRIF action per se, using this system, may provide
important insights into the molecular mechanisms that regu-
late protein sorting and secretion.
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